MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    A genome-wide genetic pleiotropy approach identified shared loci between multiple system atrophy and inflammatory bowel/Crohn’s disease

    A. Shadrin, A. Sreelatha, S. Mucha, C. Blauwendraat, O. Frei, D. Ellinghaus, A. Franke, G. Wenning, A. Singleton, T. Gasser, H. Houlden, S. Scholz, O. Andreassen, M. Sharma (Oslo, Norway)

    Objective: The aim of this study to understand and define genetic overlap between multiple system atrophy (MSA) and autoimmune diseases such as Crohn’s disease (CD),…
  • 2019 International Congress

    Intronic pentanucleotide TTTCA repeat insertions do not cause familial and sporadic cortical myoclonic tremor with epilepsy in the UK

    WY. Yau, H. Houlden (London, United Kingdom)

    Objective: To ascertain whether intronic TTTCA repeat insertions in the SAMD12, TNRC6Aand RAPGEF2 genes cause benign adult familial myoclonic epilepsy (BAFME) and progressive myoclonic epilepsy in the UK. Background:…
  • 2019 International Congress

    A case report of two siblings Aicardi-Goutières Syndrome type 2

    C. Fujiwara Murakami, E. Nakagawa, A. Meira, F. Germiniani, E. Pereira, H. Ghizoni Teive (Curitiba, Brazil)

    Objective: To report two sisters with late diagnosis of Aicardi-Goutières Syndrome 2. Background: Aicardi-Goutières Syndrome (AGS) is a rare encephalopathy characterized by basal ganglia calcification,…
  • 2019 International Congress

    Neurological Wilson Disease: Clinical Aspects and Evolution in 10 Cases

    Y. Mecheri, F. Serradj, A. Boulefkhad, H. Semra, A. Mzahem, A. Hamri, Y. Sifi (Constantine, Algeria)

    Objective: Describe the clinical aspects and evolution in 10 patients with neurological Wilson's disease (NWD). Background: Wilson's disease (WD) is a rare autosomal recessive metabolic…
  • 2019 International Congress

    Neuropathology in a case of HD-like syndrome caused by mutations in RNF216

    P. Santens, A. Sieben, B. Dermaut (Ghent, Belgium)

    Objective: To describe the neuropathology in a rare case of autosomal recessive HD like syndrome due to homozygous RNF216 mutations. To confirm the hypothesis of…
  • 2019 International Congress

    The Role of Dysfunctional BDNF in Remodeling the Parkinsonian Striatum Following Dopamine Neuron Grafting in CRISPR rs6265 Rats

    N. Mercado, J. Stancati, T. Collier, C. Sortwell, I. Sandoval, C. Kemp, B. Daley, M. Duffy, K. Steece-Collier (Grand Rapids, MI, USA)

    Objective: To evaluate the impact of the rs6265 Bdnf single nucleotide polymorphism (SNP) on function & synaptic integration of primary dopamine (DA) neuron grafts in…
  • 2019 International Congress

    Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease?

    M. Figorilli, A. Marques, M. Meloni, B. Pereira, M. Puligheddu, F. Durif, ML. Fantini (Clermont-Ferrand, France)

    Objective: We aim to longitudinally evaluate clinical and neurophysiological features of REM sleep behavior disorder (RBD), including REM Sleep Without Atonia (RSWA) in Parkinson’s Disease…
  • 2019 International Congress

    Evaluation of Retinal Layers in Restless Legs Syndrome

    N. Ongun, G. Ongun (Burdur, Turkey)

    Objective: The aim of this study is to investigate the possible relationship between restless leg syndrome (RLS) and retinal thickness. Background: Dopamine is the major…
  • 2019 International Congress

    Parkinson’s Disease Treatments and Outcomes: US v Non-US Patients

    TL. Davis, M. Rafferty, K. Lyons, A. Ramirez-Zamora, H. Gao, S. Wu, F. Cubilllos, EC. Nelson (Lebanon, NH, USA)

    Objective: To determine if there are differences in treatment patterns and outcomes in US patients, who often must pay for some of their care, and…
  • 2019 International Congress

    Pre-Dopa DBS: is early deep brain stimulation able to modify the natural course of Parkinson’s disease?

    M. Porta, D. Servello, AR. Bona, E. Zekaj, G. Gonzalez-Escamilla, G. Groppa (Milan, Italy)

    Objective: We review the state-of-the-art for deep brain stimulation (DBS) in Parkinson’s disease (PD) management, and present a case-series to evaluate the potential of DBS…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley